CHEVALLARD DANIEL R. (Chief Financial Officer) purchased 139.2% of their position (7.50K shares) of LENZ THERAPEUTICS, INC. on the open market
Open‑market purchase worth $64.3K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/30/2026ACC: 0001706176-26-000004
Officer· Chief Financial Officer
Since Mar 2024
+7.50K
Net shares
Net buyer
$64.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
7.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+7.50K
Price / share
$8.57
Trade value
$64.28K
% of position
139.2%
3/27/2026
5.39K→12.89K
Total
Net shares
+7.50K
Net value
$64.28K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/27/2026 | P · Purchase | +7.50K | $8.57 | $64.28K | 139.2% | 5.39K | 12.89K |
| Total | +7.50K | $64.28K | ||||||
Derivative Transactions0
No derivative transactions reported